Role of interleukin 16 in multiple myeloma.

  • Djordje Atanackovic
  • York Hildebrandt
  • Julia Templin
  • Yanran Cao
  • Christiane Keller
  • Jens Panse
  • Sabrina Meyer
  • Henrike Reinhard
  • Katrin Bartels
  • Nesrine Lajmi
  • Orhan Sezer
  • Axel R. Zander
  • Andreas Marx
  • Ria Uhlig
  • Jozef Zustin
  • Carsten Bokemeyer
  • Nicolaus Kröger

Abstract

Multiple myeloma is a malignancy characterized by the expansion of a plasma cell clone that localizes to the human bone marrow. Myeloma cells and bone marrow stromal cells produce soluble factors that promote the survival and progression of multiple myeloma. Interleukin 16 (IL-16) is involved in regulating the migration and proliferation of normal leukocytes. However, the role of IL-16 in human cancers, including multiple myeloma, is unclear.

Bibliografische Daten

OriginalspracheEnglisch
Aufsatznummer13
ISSN0027-8874
StatusVeröffentlicht - 2012
pubmed 22745469